A Studypain relief and assess recovery using intravenous Lignocaine in Laparoscopic Surgeries.

A Prospective Randomised Study to Evaluate the Analgesic Efficacy and Quality of Recovery of Peri-operative Intravenous Lignocaine Infusion in Laparoscopic Surgeries. - LILS

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/07/026750

Enrollment

Registered

2020-07-23

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Control Intervention1: Inj lignocaine given bolus and as infusion: Lignocaine 1.5mg/kg iv bolus diluted to 10ml with normal saline and 1.5mg/kg/hr iv infusion was continued till 15minutes post-operati

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 or 2, elective laparoscopic surgeries, duration of surgery of 2 hours, elective laparoscopic surgeries, BMI 18-26.

Exclusion criteria

Exclusion criteria: Patient refusal, pregnant females known allergy to study drugs

Design outcomes

Primary

Measure	Time frame
1)to evaluate the analgesic efficacy of intra-operatively lignocaine infused patients, effectiveness of lignocaine infusion on pressor response at intubation and extubation 2) the effect of intravenous lignocaine on post-operative analgesiaTimepoint: 0, 2, 4, 6, 12, 18, 24 hours	—

Secondary

Measure	Time frame
1)any side effects of intravenous lidocaine infusions, 2)the role of i.v. lignocaine on return of bowel movements postoperatively 3)and its effect on the time to discharge from the hospitalTimepoint: 0,2,4,6,12,18, 24 hours observation for the above	—

Countries

India

Contacts

Public ContactPriyabrat Karan

Ruby hall clinic, pune

rajmeenal@hotmail.com09822053176

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026